Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 391 to 400 of 1090 total matches.
A Low-Dose Doxycycline (Oracea) for Rosacea
The Medical Letter on Drugs and Therapeutics • Jan 15, 2007 (Issue 1252)
, M.D., Albert Einstein College of Medicine
DRUG INTERACTIONS FELLOW: Emily Ung, BScPhm, Children’s ...
A new once-daily, low-dose oral formulation of doxycycline monohydrate (Oracea - CollaGenex) has been approved by the FDA for treatment of inflammatory papules and pustules associated with rosacea in adults.
Pramipexole and Ropinirole for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Nov 21, 1997 (Issue 1014)
and can make dyskinesias worse.
DRUG INTERACTIONS — Cimetidine (Tagamet, and others), which inhibits ...
Pramipexole (Mirapex - Pharmacia & Upjohn) and ropinirole (Requip - SmithKline Beecham), two new dopamine agonists, have been approved by the US Food and Drug Administration (FDA) for treatment of both early (without levodopa) and advanced (with levodopa) Parkinson's disease. Bromocriptine (Parlodel) and pergolide (Permax) are older dopamine agonists marketed in the USA for adjunctive use with levodopa.
Desloratadine (Clarinex)
The Medical Letter on Drugs and Therapeutics • Mar 18, 2002 (Issue 1126)
incidence of adverse effects, including anticholinergic effects, should be kept in mind.
DRUG INTERACTIONS ...
Desloratadine (des lor at' a deen; Clarinex - Schering), an active metabolite of the H1-receptor antagonist loratadine (Claritin), has been approved by the FDA for oral treatment of allergic rhinitis and chronic urticaria in patients at least 12 years old. The patent for loratadine expires in December 2002, and generic or over-the-counter versions are expected.
Isavuconazonium Sulfate (Cresemba) - A New Antifungal
The Medical Letter on Drugs and Therapeutics • Mar 14, 2016 (Issue 1490)
studies
in pregnant women) for use during pregnancy.
DRUG INTERACTIONS — Isavuconazole is a substrate ...
The FDA has approved isavuconazonium sulfate
(Cresemba – Astellas) for intravenous and oral treatment
of invasive aspergillosis and invasive mucormycosis
in adults. Isavuconazonium sulfate is a prodrug of
isavuconazole, a broad-spectrum triazole antifungal.
Silodosin (Rapaflo) for Benign Prostatic Hyperplasia
The Medical Letter on Drugs and Therapeutics • Jan 12, 2009 (Issue 1303)
of cataract surgery in patients taking tamsulosin, has also been reported with silodosin.
DRUG INTERACTIONS ...
Silodosin (Rapaflo - Watson Pharmaceuticals), an alpha1a-adrenoreceptor selective antagonist, has been approved by the FDA for treatment of benign prostatic hyperplasia (BPH). Some medications for BPH are listed in the table on page 4. Alpha1 blockers are commonly used with 5a-reductase inhibitors such as finasteride, which can shrink the size of the prostate, but may take months to do so.
In Brief: One Drop or Two
The Medical Letter on Drugs and Therapeutics • Jun 19, 2006 (Issue 1237)
in
patients who took these drugs during childhood.
4-6
DRUG INTERACTIONS — The methylphenidate
patch should ...
Many prescriptions for eye drops call for instillation of 1-2 drops. But Medical Letter consultants in ophthalmology seem to agree that all eye drops should generally be given in doses of only one drop. The volume of a single drop can vary with the viscosity of the solution, the design of the dropper, and patient technique. The average volume of a drop is 35-50 microliters, but can be as high as 75 microliters. An eye brimming with fluid holds 30 microliters at best, so even one drop is often an overdose. A second either washes out the first or increases the possibility of systemic toxicity,...
Transdermal Rotigotine (Neupro) for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Aug 27, 2007 (Issue 1268)
EDITOR, DRUG INTERACTIONS: Philip D. Hansten,
Pharm.D., University of Washington
ADVISORY BOARD ...
Rotigotine (Neupro - Schwarz Pharma), a nonergot dopamine agonist in a transdermal patch formulation, was recently approved by the FDA for treatment of early Parkinson's disease (PD).
Prostate Cancer Screening
The Medical Letter on Drugs and Therapeutics • Nov 03, 2008 (Issue 1298)
Eric J. Epstein, M.D. Albert Einstein College of Medicine
CONTRIBUTING EDITOR, DRUG INTERACTIONS ...
The US Preventive Services Task Force (USPSTF) has recently concluded that available evidence is insufficient to assess the balance between potential benefits and harms of using the prostate-specific antigen (PSA) to screen men < 75 years old for prostate cancer and has recommended against screening men > 75 years old.
Topiramate for Epilepsy
The Medical Letter on Drugs and Therapeutics • May 23, 1997 (Issue 1001)
pregnancy.
DRUG INTERACTIONS — In patients with high serum phenytoin concentrations, addition ...
Topiramate (Topamax - Ortho-McNeil) has been approved by the US Food and Drug Administration (FDA) for oral use as an adjunct to other drugs in adult patients with partial seizures. Since this diagnostic category includes the largest number of patients with refractory epilepsy, new drugs with antiepileptic activity are usually tried first for this indication. Topiramate (toe pyre' a mate) is a structurally unique agent chemically related to the D-enantiomer of fructose.
Modafinil for Narcolepsy
The Medical Letter on Drugs and Therapeutics • Mar 26, 1999 (Issue 1049)
elimination half-life is about 15 hours.
DRUG INTERACTIONS — Modafinil is metabolized in part by CYP3A4 ...
Modafinil (Provigil), a benzhydryl sulfinylacetamide non-amphetamine stimulant that has been used in Europe since 1995, has now been approved by the FDA for treatment of excessive daytime sleepiness associated with narcolepsy.